Google releases AI tool for understanding the human genome

Google has released DeepVariant, its artificial intelligence (AI) tool, capable of building a person’s genome from sequencing data.

Developed by the Google Brain team and Verily, an Alphabet subsidiary, DeepVariant identifies insertion and deletion mutations and single-base-pair mutations to build an accurate picture of an individual’s genome. Researchers collected data on high-throughput reads and full genomes from the Genome in a Bottle (GIAB) project to train a deep-learning system to accurately present data.

“The success of DeepVariant is important because it demonstrates that in genomics, deep learning can be used to automatically train systems that perform better than complicated hand-engineered systems,” said Brendan Frey, CEO of Deep Genomics.

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.